Clinical Trial Update: Specialized Center of Research in Occupational and Immunologic Lung Disease

View source ↗

Summary

A clinical trial update noting completion for a NHLBI-sponsored study on occupational and immunologic lung diseases.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asbestosis
• Chronic Obstructive Pulmonary Disease
• Pneumoconiosis
• Silicosis

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Lung Diseases, Obstructive, Asbestosis | Status: COMPLETED